Quick Answer
Park Ha Biological Technology Co., Ltd. reported Operating Income Loss of -$24.15 million for the year ending 2025.
- Park Ha Biological Technology Co., Ltd. showed a decrease of -3,142.5% in Operating Income Loss from 2024 to 2025.
- This data is from Park Ha Biological Technology Co., Ltd.'s annual report (Form 10-K), filed with the SEC on March 2, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2022 to 2025), Park Ha Biological Technology Co., Ltd.'s Operating Income Loss has declined by 12,356.8%.
- Historical annual values: Fiscal year 2025: -$24.15 million | Fiscal year 2024: $793.7 thousand | Fiscal year 2023: $1.18 million | Fiscal year 2022: $197.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: